S 414, the ADS for Mental Health Services Act, requires major social media platforms and search engines (with over 100 million monthly users) to annually report to the Federal Trade Commission (FTC) on public service advertisements promoting mental, behavioral, or physical health resources. The reports must detail the number and value of such ads, including those highlighting free local services or addressing issues like suicide prevention, addiction, or social isolation. The FTC must then summarize this data for Congress annually, without altering existing privacy or data security laws. This bill directly affects large digital platforms by mandating transparency about health-focused public service advertising.
This bill requires the CDC to collect and publicly share information about concussions and traumatic brain injuries (TBIs) affecting public safety officers, including research on prevention, diagnosis, and treatment. The CDC must update its website and develop outreach to medical professionals, public safety employers, mental health providers, patients, and educational institutions to improve care and awareness. It directly affects law enforcement, firefighters, and other public safety officers by creating a centralized resource for evidence-based practices to address TBIs in their work. The bill focuses on information dissemination, not new funding or mandates, to support better health outcomes for this workforce.
The Mental Health TALK SAFE Act of 2026 amends the Controlled Substances Act to allow telehealth prescribing of certain controlled substances for mental health treatment. It establishes requirements for telehealth entities that prescribe these substances, including minimum staffing standards (like employing at least 250 psychiatrists working 30+ hours weekly), mandatory compliance officers, and restrictions on practitioner compensation structures. The bill prohibits pharmacists from refusing to fill prescriptions issued via telehealth based solely on the method of evaluation, requiring them to attempt validation through communication with the patient or prescriber first. It affects telehealth entities, psychiatrists, and psychiatric-mental health advanced practice nurses providing remote mental health care services. The legislation preempts state laws that would restrict these telehealth prescribing practices for mental health conditions.
This bill amends the Social Security Act to include the District of Columbia as an eligible jurisdiction for the Rural Health Transformation Program, which previously only covered the 50 states. It directly affects District of Columbia healthcare providers and patients who were previously excluded from this federal program. The key provision inserts "and the District of Columbia" into the eligibility language of Section 2105(h)(2)(D) of the Social Security Act. This change ensures D.C. qualifies for the same program benefits as rural areas in states. The amendment applies retroactively as if enacted on a specified date.
Tags
Rural Communities
Lung Cancer Screening and Prevention Act of 2025 This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the Food and Drug Administration, regardless of whether they are recommended by the United States Preventive Services Task Force. The Centers for Medicare & Medicaid Services must set coverage and payment limits for such tests. (Currently, Medicare covers screening tests for the early detection of lung cancer if they are recommended by the task force.)
S 825 requires the Justice Department to develop a report within 150 days on programs providing evidence-based mental health care for public safety officers, including police, firefighters, EMTs, and 911 dispatchers. The report must outline how to deliver trauma-informed care, peer support, and family services through in-person or telehealth options, while ensuring confidentiality for officers seeking help. It also needs to detail administrative efficiency across states and territories, draft necessary grant conditions, and estimate annual funding needs. This bill does not fund programs but sets a framework for future action based on the high rates of PTSD and suicide among these frontline workers.
HR 593 exempts certain health profession loan repayments and scholarship payments from federal income tax. It applies to individuals participating in Public Health Service Act programs (like sections 338B, 846, and 338K) and state programs designed to increase healthcare access in underserved areas. The bill also includes scholarships under the Native Hawaiian Health Care Improvement Act in this tax exclusion. These changes take effect for payments received after the bill's enactment date.
The SCREENS for Cancer Act of 2025 reauthorizes and strengthens the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which provides free or low-cost screening and diagnostic services to low-income, uninsured, or underinsured women. The bill increases annual funding to $235 million for fiscal years 2026-2030, expands the program’s focus to include cancer prevention alongside detection and control, and adds specific requirements to reduce health disparities and improve access for underserved populations. Key provisions include updated guidelines for follow-up care, enhanced patient navigation services, and a requirement for a GAO report by 2027 assessing program eligibility, service trends, and barriers to screening. The program directly serves women across all 50 states, the District of Columbia, territories, and tribal organizations, building on its existing record of providing over 16.5 million screenings to 6.4 million people since 1991.
This bill reauthorizes funding for existing mental health support programs designed to assist law enforcement officers experiencing crisis. It extends the authorization period for these programs from 2020-2024 to 2025-2029 under Section 1001(a)(21) of the 1968 Omnibus Crime Control and Safe Streets Act. The bill directly affects law enforcement officers who access these crisis support services, ensuring continued availability of the established program. It does not create new programs but maintains current funding for existing mental health treatment and support resources for officers.
This bill exempts certain orally administered drugs from Medicare Part D's manufacturer discount program. Specifically, it excludes drugs that: (1) received FDA approval under the standard new drug application process, and (2) have been granted a narrow CMS exception allowing them to be treated as noninnovator drugs under Medicaid rebates. The exemption applies directly to these specific drugs meeting both criteria, altering how their costs are calculated under Medicare Part D. This change affects drug manufacturers and Medicare beneficiaries by modifying the discount structure for these particular medications.